Theranostics 2023; 13(1):125-147. doi:10.7150/thno.78164 This issue Cite

Review

Circulating microRNAs as emerging regulators of COVID-19

Yu Liang1,2#, Dan Fang1,3#, Xiaojun Gao1,3#, Xin Deng1,3, Ni Chen1,3, Jianbo Wu1,3, Min Zeng4✉, Mao Luo1,2,3✉

1. Key Laboratory of Medical Electrophysiology, Ministry of Education, Drug Discovery Research Center, Southwest Medical University, Luzhou, China.
2. College of Integrated Traditional Chinese and Western Medicine, Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University, Luzhou, Sichuan, China.
3. Laboratory for Cardiovascular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
4. Department of Pharmacy, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
#These authors contributed equally to this work.

Citation:
Liang Y, Fang D, Gao X, Deng X, Chen N, Wu J, Zeng M, Luo M. Circulating microRNAs as emerging regulators of COVID-19. Theranostics 2023; 13(1):125-147. doi:10.7150/thno.78164. https://www.thno.org/v13p0125.htm
Other styles

File import instruction

Abstract

Graphic abstract

Coronavirus disease 2019 (COVID-19), an infectious disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that has high incidence rates, spreads rapidly, and has caused more than 6.5 million deaths globally to date. Currently, several drugs have been used in the clinical treatment of COVID-19, including antivirals (e.g., molnupiravir, baricitinib, and remdesivir), monoclonal antibodies (e.g., etesevimab and tocilizumab), protease inhibitors (e.g., paxlovid), and glucocorticoids (e.g., dexamethasone). Increasing evidence suggests that circulating microRNAs (miRNAs) are important regulators of viral infection and antiviral immune responses, including the biological processes involved in regulating COVID-19 infection and subsequent complications. During viral infection, both viral genes and host cytokines regulate transcriptional and posttranscriptional steps affecting viral replication. Virus-encoded miRNAs are a component of the immune evasion repertoire and function by directly targeting immune functions. Moreover, several host circulating miRNAs can contribute to viral immune escape and play an antiviral role by not only promoting nonstructural protein (nsp) 10 expression in SARS coronavirus, but among others inhibiting NOD-like receptor pyrin domain-containing (NLRP) 3 and IL-1β transcription. Consequently, understanding the expression and mechanism of action of circulating miRNAs during SARS-CoV-2 infection will provide unexpected insights into circulating miRNA-based studies. In this review, we examined the recent progress of circulating miRNAs in the regulation of severe inflammatory response, immune dysfunction, and thrombosis caused by SARS-CoV-2 infection, discussed the mechanisms of action, and highlighted the therapeutic challenges involving miRNA and future research directions in the treatment of COVID-19.

Keywords: SARS-CoV-2, circulating miRNAs, virus infections, immune responses, COVID-19


Citation styles

APA
Liang, Y., Fang, D., Gao, X., Deng, X., Chen, N., Wu, J., Zeng, M., Luo, M. (2023). Circulating microRNAs as emerging regulators of COVID-19. Theranostics, 13(1), 125-147. https://doi.org/10.7150/thno.78164.

ACS
Liang, Y.; Fang, D.; Gao, X.; Deng, X.; Chen, N.; Wu, J.; Zeng, M.; Luo, M. Circulating microRNAs as emerging regulators of COVID-19. Theranostics 2023, 13 (1), 125-147. DOI: 10.7150/thno.78164.

NLM
Liang Y, Fang D, Gao X, Deng X, Chen N, Wu J, Zeng M, Luo M. Circulating microRNAs as emerging regulators of COVID-19. Theranostics 2023; 13(1):125-147. doi:10.7150/thno.78164. https://www.thno.org/v13p0125.htm

CSE
Liang Y, Fang D, Gao X, Deng X, Chen N, Wu J, Zeng M, Luo M. 2023. Circulating microRNAs as emerging regulators of COVID-19. Theranostics. 13(1):125-147.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.